ScholarIQanswers from OpenAlex & ORCID
David Zagzag
ResearcherPublications, citations & collaboration network
David Zagzag is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David Zagzag have?
ScholarIQindexed works
David Zagzag has 420 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David Zagzag have?
ScholarIQcitation count
David Zagzag has 33,043 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David Zagzag?
ScholarIQh-index
David Zagzag has an h-index of 84 in OpenAlex.
What is the i10-index of David Zagzag?
ScholarIQi10-index
David Zagzag has an i10-index of 235 in OpenAlex.
What is the ORCID of David Zagzag?
ScholarIQorcid
The ORCID for David Zagzag is on the source record.
What is the OpenAlex record for David Zagzag?
ScholarIQopenalex
The OpenAlex for David Zagzag is on the source record.
What are the most-cited papers on David Zagzag?
ScholarIQmost cited works
Transforming Fusions of <i>FGFR</i> and <i>TACC</i> Genes in Human Glioblastoma
Devendra Raj Singh, Joseph M. Chan, Pietro Zoppoli, Francesco Niola, Ryan J. Sullivan, Angelica Castano, Eric Minwei Liu, Jonathan Reichel, Paola Porrati, Serena Pellegatta, Kunlong Qiu, Zhibo Gao, Michele Ceccarelli, Riccardo Riccardi, Daniel J. Brat, Abhijit Guha, Ken Aldape, John G. Golfinos, David Zagzag, Tom Mikkelsen, Gaetano Finocchiaro, Anna Lasorella, Raúl Rabadán, Antonio Iavarone
Glial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging
Edmond A. Knopp, Soonmee Cha, Glyn Johnson, Avi Mazumdar, John G. Golfinos, David Zagzag, Douglas C. Miller, Patrick J. Kelly, Irvin I. Kricheff
Gliomas: Predicting Time to Progression or Survival with Cerebral Blood Volume Measurements at Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging
Meng Law, Robert J. Young, James S. Babb, N. Peccerelli, Sophie Chheang, Michael L. Gruber, Douglas C. Miller, John G. Golfinos, David Zagzag, Glyn Johnson
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Meng Law, Stanley Yang, James S Babb, Edmond A. Knopp, John G. Golfinos, David Zagzag, Glyn Johnson
Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival
Ashwatha Narayana, Patrick D. Kelly, John G. Golfinos, Erik Parker, Glyn Johnson, Edmond A. Knopp, David Zagzag, Ingeborg Fischer, Shahzad Raza, Praveen Medabalmi, Patricia Eagan, Michael L. Gruber